Veeva Systems (VEEV) Q2 FY2027 Earnings Call: Q&A Summary

Q: How are customers viewing the adoption of new offerings like Vault application agents and Falcon amidst a positive R&D spending environment?

A: Peter Gassner, CEO, noted that while customers have many priorities, Falcon is a high priority due to its potential for cost savings and compliance. He stated that Veeva is currently the rate limiter as they work to get the product ready for early adopters.

Q: Are the various modes of engagement like Falcon and custom development frameworks changing the financial model?

A: Peter Gassner, CEO, explained that agentic labor is a fourth category for Veeva alongside cloud software, data, and consulting. He noted this is a structural advantage that transforms the customer discussion.

Q: What drove the acceleration in the commercial segment subscription line item?

A: Brian Van Wagener, CFO, reported that commercial subscriptions were up about 13% year-over-year, with broad-based strength across CRM, content, data, Crossix, and Astra.

Q: How should investors think about the market opportunity and investments for Aspen?

A: Peter Gassner, CEO, described Aspen as a startup inside Veeva focused on horizontal CRM. He stated the market is clear, and the investment is small on the Veeva scale, not acting as a financial drain.

Q: Is the selling cycle for Falcon different, and are there difficulties in shifting budgets from IT to HR?

A: Peter Gassner, CEO, stated the selling cycle is easier because IT is not involved in agentic labor. He noted they are selling to business unit heads, and about 60% of the sales process is a business sell.

Q: Should investors expect an uptick in sales and R&D investments for Falcon, Aspen, and other AI products?

A: Brian Van Wagener, CFO, said they scale investment as they scale revenue, with nothing material for this fiscal year as it is already factored into their FY '27 guidance.

Q: What is the outlook for winning back customers who chose Salesforce for CRM?

A: Peter Gassner, CEO, noted that some large customers are experiencing project delays with Salesforce. He expressed optimism about win-backs in 2027 and 2028 as backstops end.

Q: What is the status of the R&D subscription line and the transition between older and newer products?

A: Brian Van Wagener, CFO, explained they are transitioning from older products like eTMF and CTMS to newer growth areas like EDC, Safety, and LIMS, which have significant headroom.

Q: What are the key readiness gates for Falcon and how will human-in-the-loop requirements evolve?

A: Peter Gassner, CEO, explained that non-deterministic models require training and guardrails. He noted that customers are now familiar with AI and want a partner that can scale it.

Q: Where is Data Cloud proving most differentiated and how is it positioned for AI outcomes?

A: Peter Gassner, CEO, stated Data Cloud is an accelerator rather than a prerequisite for AI. He highlighted momentum in OpenData, Compass, and Link products.

Q: Are early adopters of Falcon exclusively sponsors, or are service providers also approaching Veeva?

A: Peter Gassner, CEO, said they are focusing on sponsors first and have not engaged heavily with service providers yet.

Q: How do you view the China market opportunity for Veeva?

A: Peter Gassner, CEO, stated the China business is growing, profitable, and synergistic with their global products.

Q: How does the Aspen pricing model work?

A: Peter Gassner, CEO, described the pricing as simple and modeled after Amazon Web Services, aiming for predictability with some overage charges.

Q: How should investors think about the impact of AI products on margins?

A: Peter Gassner, CEO, stated that gross margins should be similar to software as they push work into deterministic software, and he expects model costs to decrease over time.

Q: Can you provide more precision on the timing of growth inflections for R&D products?

A: Brian Van Wagener, CFO, stated that products like EDC, eCOA, RTSM, Safety, and LIMS are all large and strategic, and while they are in early stages, the company is confident in its 2030 goals.

Q: What is the ideal customer profile for Aspen?

A: Peter Gassner, CEO, said the ideal profile is nimble companies and young tech startups that want to work innovatively.

Q: Will the work shifting to Falcon displace internal teams or CROs?

A: Peter Gassner, CEO, said it will be a combination of internal and outsourced work, though generally not displacing CROs. He noted that pricing will likely involve enterprise license agreements.

Q: Is the confidence in CRM win-backs based on customer conversations or Salesforce delays?

A: Paul Shawah, EVP, Strategy, stated the confidence is based on Veeva's execution, trust, and the fact that they have over 180 customers live, contrasting with Salesforce's struggles.

Q: What are customers focused on outside of agentic labor given the steadier macro backdrop?

A: Peter Gassner, CEO, noted that the life sciences industry has become accustomed to moving parts and is executing well, focusing on getting the job done.

Q: How are the ramping EDC deals progressing?

A: Peter Gassner, CEO, noted that EDC has long implementation cycles and they currently have 9 of the top 20 customers, with confidence in long-term progress.

Q: How is the partnership with IQVIA progressing?

A: Peter Gassner, CEO, stated they are very happy with the partnership, noting that both companies are major players and collaboration helps the industry grow.

Q: What drove the double-digit growth in the Commercial Cloud business?

A: Brian Van Wagener, CFO, attributed the growth to broad-based strength across CRM, content, data, and Crossix.

Q: How does tech-enabled consulting impact efficiency and customer success?

A: Peter Gassner, CEO, explained that tech-enabling services makes software more valuable by speeding up implementations, leading to a renaissance for specialized tech-enabled services.

Q: How should investors think about the management change regarding Tom Schwenger?

A: Peter Gassner, CEO, stated that Tom is moving to a partner company and his departure will not affect the CRM business, as those relationships are enduring.

Q: What drove the recent top 20 biopharma wins for Vault CRM?

A: Paul Shawah, EVP, Strategy, cited trust and product excellence as the primary drivers, noting that 12 of the top 20 have committed to Vault CRM.

Q: Does the desire for AI from incumbent platforms create an opportunity for M&A?

A: Peter Gassner, CEO, noted that customers want to avoid experimentation with small vendors, and while they are discerning with M&A, they are not dependent on it for the Falcon product.

Q: What specific problems is Aspen aiming to solve compared to horizontal CRM platforms?

A: Peter Gassner, CEO, cited unpredictable pricing, vendor tangibility, scalability, and excessive data entry as key problems Aspen aims to solve.

Q: Are pharma marketing budgets improving, and is AI acting as a catalyst?

A: Paul Shawah, EVP, Strategy, confirmed strength in pharma marketing budgets and noted that AI is a tailwind for Crossix as it becomes a more important channel for measurement.